English
EspañolOur statements
IAPO develops and uses statements to help shape outcomes of meetings and strategies and to urge policy makers and other relevant stakeholders to take specific action on patient-centred healthcare.
Our statements serve as key advocacy resources to support our member organizations and patient-centred healthcare advocates. Find out more about IAPO’s statements below.
WHO Executive Board Statements
The World Health Organization Executive Board (WHO EB) puts into practice the policies and decisions made at the World Health Assembly (WHA), WHO’s decision-making body. During the annual WHO EB meeting in January, EB members agree upon the agenda and the resolutions to be considered at the upcoming WHA.
IAPO delivers statements at the annual WHO EB meeting, prepared together with the Board and partners, to push for patient-centred healthcare to be considered within certain agenda items. This is important because it raises the profile of patient-centred healthcare on the global health agenda and works toward establishing commitments and global policies on patient-centred healthcare.
World Health Assembly Statements
The WHA is the decision-making body of WHO and is held annually in Geneva, Switzerland. It is attended by delegations from all WHO Member States and, thanks to IAPO’s official relations status with the World Health Organization, we leverage this meeting by delivering statements made in consultation with IAPO members to influence global policies and commitments on World Health Assembly Statements.
World Health Assembly 74 - 2021
- Agenda Item 13. 1 Global action on patient safety
- Agenda item 13.2 Political declaration on NCDs and Agenda item 13.3 Expanding access to effective treatments for cancer and rare and orphan diseases
- Agenda Item 13.7 Standardization of medical devices nomenclature
- Constituency Statement on Agenda item 17 and Agenda item 18
World Health Assembly 75 - 2022
- Agenda Item 14.1 (a) Draft implementation road map 2023–2030 for the global action plan for the prevention and control of noncommunicable diseases 2013–2030
- Agenda Item 14.1 (e) Progress in the implementation of the global strategy to accelerate the elimination of cervical cancer as a public health problem and its associated goals and targets for the period 2020–2030
- Agenda Item 14.8 Standardization of medical devices nomenclature
- Agenda Item 16.2 Strengthening WHO preparedness for and response to health emergencies